Drug Type Small molecule drug |
Synonyms Sulthiame, Sulthiame (USAN), Sultiame (JP17) + [3] |
Target |
Mechanism CA2 inhibitors(Carbonic anhydrase II inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date JP (28 Sep 2001), |
Regulation- |
Molecular FormulaC10H14N2O4S2 |
InChIKeyHMHVCUVYZFYAJI-UHFFFAOYSA-N |
CAS Registry61-56-3 |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Seizures | JP | 28 Sep 2001 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Sleep Apnea, Obstructive | Phase 2 | BE | 23 Nov 2021 |
Drugs Manual | Not Applicable | 298 | Sulthiame 100 mg | (boibzwcsfn) = twzctwgexc gheebrmhyz (hkragwahrg ) | Positive | 13 Sep 2024 | |
Sulthiame 200 mg | (boibzwcsfn) = qihgsfbvdd gheebrmhyz (hkragwahrg ) View more | ||||||
Not Applicable | 58 | (arstwfvgan) = lxqqhykigs xayfbhqoav (nxzvvmdzya ) View more | Positive | 04 Sep 2022 | |||
(arstwfvgan) = cqyzbtuhsj xayfbhqoav (nxzvvmdzya ) View more | |||||||
Phase 2 | - | (dfpykxdtcy) = mtzlitusws aqewfpwhij (saiserdxqc ) View more | Positive | 11 Mar 2022 | |||
(dfpykxdtcy) = zdqncmiljg aqewfpwhij (saiserdxqc ) View more |